Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

This trial studies how well low-dose lenalidomide works compared with high-dose lenalidomide in treating younger patients

January 19, 2016